In individuals with obesity-related insulin resistance, hypertrophied adipocytes exhibit increased secretion of pro-inflammatory cytokines, such as TNF-α, IL-6, and IL-1β, all of which impair insulin signaling by activating NF-κB and JNK pathways [31]. Here, IL1B is linked to obesity disorder.